Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Colorectal Neoplasms 10Breast Neoplasms 10Prostatic Neoplasms 9Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Multiple Myeloma 3Lymphoma 3Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematopoietic and Lymphoid System Neoplasm 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Prostate Cancer Patients 1

Interventions

Cyclophosphamide 56fludarabine 30Methotrexate 24blinatumomab 23Dexamethasone 21Cytarabine 21Vincristine 19venetoclax 18Specimen Handling 16fludarabine phosphate 15Whole-Body Irradiation 13Stem Cell Transplantation 12Biopsy 12Tacrolimus 10Mycophenolic Acid 10Immunotherapy, Adoptive 10Daunorubicin 10Thiotepa 9Rituximab 9Prednisone 9Mercaptopurine 9Melphalan 9Magnetic Resonance Spectroscopy 8Doxorubicin 8pegaspargase 7Granulocyte Colony-Stimulating Factor 7Cyclosporine 7olverembatinib 6Mesna 6Inotuzumab Ozogamicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Interviews as Topic × Clear all
NCT06323044 2026-03-24

MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence

Roswell Park Cancer Institute

Phase NA Recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡